Effect of Exposure to Small Pharmaceutical Promotional Items on Treatment Preferences
Frosch, Dominick L.
Perkins, Andrew W.
Kahn, Barbara E.
Archives of Internal Medicine 2009 May 11; 169(9): 887-893
BACKGROUND: Policy discussions concerning pharmaceutical promotion often assume that small promotional items are unlikely to influence prescribing behavior. Our experiment measures whether exposure to these items results in more favorable attitudes toward marketed products and whether policies that restrict pharmaceutical marketing mitigate this effect. METHODS: This is a randomized controlled experiment of 352 third- and fourth-year medical students at two US medical schools with differing policies toward pharmaceutical marketing. Participants assigned to treatment were exposed to small branded promotional items for Lipitor (atorvastatin) without knowledge that the exposure was part of the study. We measured differences in implicit (ie, unconscious) attitudes toward Lipitor and Zocor (simvastatin) in exposed and control groups with the Implicit Association Test (IAT). Self-reported attitudes were also measured, and a follow-up survey was administered measuring attitudes toward marketing. RESULTS: Fourth-year students at the University of Miami Miller School of Medicine exposed to Lipitor promotional items had more favorable implicit attitudes about that brand-name drug compared to the control group (IAT effect: 0.66 vs 0.47; P = .05), while the effect was reversed at the University of Pennsylvania School of Medicine (IAT effect: 0.22 vs 0.52; P = .002) where restrictive policies are in place limiting pharmaceutical marketing (interaction effect: P = .003). No significant effect was observed among third-year students. On a "skepticism" scale, University of Miami students held more favorable attitudes toward pharmaceutical marketing compared to University of Pennsylvania students (0.55 vs 0.42; P
Showing items related by title, author, creator and subject.
A Decade of Controversy: Balancing Policy With Evidence in the Regulation of Prescription Drug Advertising Frosch, Dominick L.; Grande, David; Tarn, Derjung M.; Kravitz, Richard L. (2010-01)Direct-to-consumer advertising (DTCA) of prescription drugs has remained controversial since regulations were liberalized by the Food and Drug Administration in 1997. We reviewed empirical evidence addressing the claims ...
The Effect of Physician's Explanations on Patients' Treatment Preferences: Five-Year Survival Data Mazur, Dennis J; Hickam, David H (1994-07)
McNeill, Paul M.; Kerridge, Ian H.; Arciuli, Catherine; Henry, David A.; Macdonald, Graham J.; Day, Richard O.; Hill, Suzanne R. (2006)